Apolipoprotein E (APOE) Genotyping, Cardiovascular Risk
Order Name
APO E MUT
Test Number: 2015053
Revision Date 12/12/2022
Test Number: 2015053
Revision Date 12/12/2022
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
Apolipoprotein E (APOE) Genotyping, Cardiovascular Risk
|
Polymerase Chain Reaction/Fluorescence Monitoring | 21619-2 |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | 5 mL (0.5 mL) | Whole Blood | EDTA (Lavender Top) | Room Temperature |
| Instructions | Notes: 0.5 mL (Note: This volume Does NOT allow for repeat testing) Specimen Type: Lavender-top (EDTA) tube (PREFERRED) or yellow-top (ACD) tube Specimen Storage: Maintain specimen at room temperature. Stability: Room temperature up to 8 days Specimen Collection: Not Available Special Instructions: Testing is performed at Esoterix Coagulation Laboratory UY#300977 |
|||
| GENERAL INFORMATION | |
|---|---|
| Expected TAT | 5-7 Days |
| Clinical Use | This test is not recommended for nonsymptomatic patients under 18 years of age. Hyperlipoproteinemia III (HPL III) is characterized by increased cholesterol and triglyceride levels, presence of B-VLDL, xanthomas, and premature vascular disease including coronary heart disease (CHD) and peripheral artery disease. |
| Performing Labcorp Test Code | 503935 |
| Notes | Labcorp Test Code: 503935 |
| CPT Code(s) | 81401 |
| Lab Section | Reference Lab |